UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is polyethylene glycol allergy a real contraindication to COVID-19 mRNA vaccines?

European annals of allergy and clinical immunology, 2023-09, Vol.55 (5), p.243

2023

Volltextzugriff (PDF)

Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma

JNCI : Journal of the National Cancer Institute, 1997-01, Vol.89 (2), p.139-147

1997

Volltextzugriff (PDF)

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

Journal of clinical oncology, 1997-11, Vol.15 (11), p.3363-3367

1997

Volltextzugriff (PDF)

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game

European journal of cancer (1990), 2002-06, Vol.38 (9), p.1181-1188

2002

Volltextzugriff (PDF)

More About: Prognostic Importance of Low c-erbB2 Expression in Breast Tumors

JNCI : Journal of the National Cancer Institute, 2000-09, Vol.92 (17), p.1443-1444

2000

Volltextzugriff (PDF)

Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck

European journal of cancer (1990), 2003-05, Vol.39 (7), p.1019-1029

2003

Volltextzugriff (PDF)

Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments

The International journal of biological markers, 2001-04, Vol.16 (2), p.87-96

2001

Volltextzugriff (PDF)

The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer

The International journal of biological markers, 2004-10, Vol.19 (4), p.282-288

2004

Volltextzugriff (PDF)

Evaluation of HER-2/neu in serum and tissue of primary and metastatic breast cancer patients using an automated enzyme immunoassay

The International journal of biological markers, 2001-10, Vol.16 (4), p.255-261

2001

Volltextzugriff (PDF)

A prediction model for breast cancer recurrence after adjuvant hormone therapy

The International journal of biological markers, 2008-10, Vol.23 (4), p.199-206

2008

Volltextzugriff (PDF)

Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs) : Results of a prospective multicenter observational study

The International journal of biological markers, 2005-07, Vol.20 (3), p.156-168

2005

Volltextzugriff (PDF)

An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requests

Clinical chemistry and laboratory medicine, 2014-06, Vol.52 (6), p.889

2014

Volltextzugriff (PDF)

Interchangeability between control material and patient serum in tumor biomarker assessment

The International journal of biological markers, 2003-07, Vol.18 (3), p.230-231

2003

Volltextzugriff (PDF)

Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate

International journal of cancer, 2004-12, Vol.112 (5), p.787-792

2004

Volltextzugriff (PDF)

Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen : Two not always related items

The International journal of biological markers, 2007-04, Vol.22 (2), p.154-158

2007

Volltextzugriff (PDF)

P21 Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer

European journal of cancer supplements, 2007, Vol.5 (8), p.36-36

2007

Volltextzugriff (PDF)

An italian program of external quality control for chromogranin A (CgA) assay : State of the art of CgA measurement

The International journal of biological markers, 2005-10, Vol.20 (4), p.264-268

2005

Volltextzugriff (PDF)

Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT)

The International journal of biological markers, 2002-07, Vol.17 (3), p.201-214

2002

Volltextzugriff (PDF)

Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma

International journal of oncology, 1999-12, Vol.15 (6), p.1169

1999

Volltextzugriff (PDF)

Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients

The International journal of biological markers, 2000-10, Vol.15 (4), p.300-307

2000

Volltextzugriff (PDF)

Tissue polypeptide antigen as a putative indicator of apoptosis

Clinical chemistry (Baltimore, Md.), 1998-09, Vol.44 (9), p.2002-2003

1998

Volltextzugriff (PDF)

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer

European journal of cancer (1990), 1995, Vol.31 (5), p.671-677

1995

Volltextzugriff (PDF)

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue

British journal of cancer, 1993-01, Vol.67 (1), p.7-9

1993

Volltextzugriff (PDF)

HER-2/neu serum levels and menopausal status

The International journal of biological markers, 2001, Vol.16 (1), p.69-70

2001

Volltextzugriff (PDF)

Comparison of the Diagnostic Accuracy of CA27.29 and CA15.3 in Primary Breast Cancer

Clinical chemistry (Baltimore, Md.), 1999-05, Vol.45 (5), p.630-637

1999

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(73)

Sprache

Englisch
(71)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(62)
Science & Technology
(54)
Life Sciences & Biomedicine
(53)
Female
(44)
Oncology
(40)
Biological And Medical Sciences
(38)
Medical Sciences
(37)
Middle Aged
(32)
Aged
(27)
Adult
(25)
Tumors
(23)
Breast Neoplasms - Pathology
(17)
Gynecology. Andrology. Obstetrics
(17)
Prognosis
(17)
Mammary Gland Diseases
(16)
Biomarkers, Tumor - Analysis
(15)
Breast Cancer
(15)
Biotechnology & Applied Microbiology
(14)
Breast Neoplasms - Chemistry
(14)
Receptors, Estrogen - Analysis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is polyethylene glycol allergy a real contraindication to COVID-19 mRNA vaccines?

Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game

More About: Prognostic Importance of Low c-erbB2 Expression in Breast Tumors

Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck

Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments

The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer

Evaluation of HER-2/neu in serum and tissue of primary and metastatic breast cancer patients using an automated enzyme immunoassay

A prediction model for breast cancer recurrence after adjuvant hormone therapy

Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs) : Results of a prospective multicenter observational study

An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requests

Interchangeability between control material and patient serum in tumor biomarker assessment

Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate

Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen : Two not always related items

P21 Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer

An italian program of external quality control for chromogranin A (CgA) assay : State of the art of CgA measurement

Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT)

Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma

Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients

Tissue polypeptide antigen as a putative indicator of apoptosis

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue

HER-2/neu serum levels and menopausal status

Comparison of the Diagnostic Accuracy of CA27.29 and CA15.3 in Primary Breast Cancer

Suchergebnisse filtern